Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population

Sayeh Ezzikouri, Abdellah Essaid El feydi, Mustapha Benazzouz, Rajae Afifi, Latifa El kihal, Mohammed Hassar, Abdellah Akil, Pascal Pineau, Soumaya Benjelloun

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Hepatocellular carcinoma is a major malignant tumor characterized in all areas by the disparity of risk between genders. The molecular bases of such disparity are still poorly understood. DNA-methyltransferase-3B (DNMT3B) may play an oncogenic role during tumorigenesis, and its genetic variants have been consistently associated with risk of several cancers, but a single study has investigated their roles in hepatocellular carcinoma (HCC). Polymorphisms of the DNMT3B gene may influence its activity on DNA methylation in several cancers, thereby modulating susceptibility to tumorigenesis. To test this hypothesis, we investigated the association between single nucleotide polymorphism -149C > T (rs2424913) in the promoter region DNMT3B and risk of HCC in a Moroccan population. In this case-control study, the DNMT3B SNP was genotyped by polymerase chain reaction-restriction fragment length polymorphism in 96 HCCs patients and 222 healthy controls that matched for age, sex and ethnicity. Overall, we found that, the DNMT3B 149 TT genotype was not significantly associated with increased risk of HCC (adjusted odds ratio (OR), 0.86, 95% CI, 0.41-1.80, P = 0.697). Stratification analysis detected, however, a trend towards a profound risk in the female subset of patients (OR = 2.04, 95% CI, 0.77-5.42) and a lesser risk for HCV-infected patients (OR = 1.33, 95% CI, 0.43-4.17). Our findings contrast with those of previous studies performed in various cancers, which showed that individuals carrying at least one T allele have a significantly increased risk of developing cancer. In addition, we provide genetic evidence for the major difference of HCC risk between men and women. Further mechanistic studies are needed to unravel the underlying molecular mechanisms.

Original languageEnglish (US)
Pages (from-to)877-881
Number of pages5
JournalInfection, Genetics and Evolution
Volume9
Issue number5
DOIs
StatePublished - Sep 2009
Externally publishedYes

Fingerprint

methyltransferases
hepatoma
single nucleotide polymorphism
Single Nucleotide Polymorphism
Hepatocellular Carcinoma
polymorphism
promoter regions
DNA
Population
cancer
neoplasms
odds ratio
Odds Ratio
Neoplasms
carcinogenesis
Carcinogenesis
DNA methyltransferase 3B
gender
methylation
DNA methylation

Keywords

  • DNA-methyltransferase-3B
  • Hepatocellular carcinoma
  • Polymorphism

ASJC Scopus subject areas

  • Ecology, Evolution, Behavior and Systematics
  • Genetics
  • Molecular Biology
  • Microbiology
  • Infectious Diseases
  • Microbiology (medical)

Cite this

Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population. / Ezzikouri, Sayeh; El feydi, Abdellah Essaid; Benazzouz, Mustapha; Afifi, Rajae; El kihal, Latifa; Hassar, Mohammed; Akil, Abdellah; Pineau, Pascal; Benjelloun, Soumaya.

In: Infection, Genetics and Evolution, Vol. 9, No. 5, 09.2009, p. 877-881.

Research output: Contribution to journalArticle

Ezzikouri, S, El feydi, AE, Benazzouz, M, Afifi, R, El kihal, L, Hassar, M, Akil, A, Pineau, P & Benjelloun, S 2009, 'Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population', Infection, Genetics and Evolution, vol. 9, no. 5, pp. 877-881. https://doi.org/10.1016/j.meegid.2009.05.012
Ezzikouri, Sayeh ; El feydi, Abdellah Essaid ; Benazzouz, Mustapha ; Afifi, Rajae ; El kihal, Latifa ; Hassar, Mohammed ; Akil, Abdellah ; Pineau, Pascal ; Benjelloun, Soumaya. / Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population. In: Infection, Genetics and Evolution. 2009 ; Vol. 9, No. 5. pp. 877-881.
@article{69594fe3502b40469f80be494a754ecb,
title = "Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population",
abstract = "Hepatocellular carcinoma is a major malignant tumor characterized in all areas by the disparity of risk between genders. The molecular bases of such disparity are still poorly understood. DNA-methyltransferase-3B (DNMT3B) may play an oncogenic role during tumorigenesis, and its genetic variants have been consistently associated with risk of several cancers, but a single study has investigated their roles in hepatocellular carcinoma (HCC). Polymorphisms of the DNMT3B gene may influence its activity on DNA methylation in several cancers, thereby modulating susceptibility to tumorigenesis. To test this hypothesis, we investigated the association between single nucleotide polymorphism -149C > T (rs2424913) in the promoter region DNMT3B and risk of HCC in a Moroccan population. In this case-control study, the DNMT3B SNP was genotyped by polymerase chain reaction-restriction fragment length polymorphism in 96 HCCs patients and 222 healthy controls that matched for age, sex and ethnicity. Overall, we found that, the DNMT3B 149 TT genotype was not significantly associated with increased risk of HCC (adjusted odds ratio (OR), 0.86, 95{\%} CI, 0.41-1.80, P = 0.697). Stratification analysis detected, however, a trend towards a profound risk in the female subset of patients (OR = 2.04, 95{\%} CI, 0.77-5.42) and a lesser risk for HCV-infected patients (OR = 1.33, 95{\%} CI, 0.43-4.17). Our findings contrast with those of previous studies performed in various cancers, which showed that individuals carrying at least one T allele have a significantly increased risk of developing cancer. In addition, we provide genetic evidence for the major difference of HCC risk between men and women. Further mechanistic studies are needed to unravel the underlying molecular mechanisms.",
keywords = "DNA-methyltransferase-3B, Hepatocellular carcinoma, Polymorphism",
author = "Sayeh Ezzikouri and {El feydi}, {Abdellah Essaid} and Mustapha Benazzouz and Rajae Afifi and {El kihal}, Latifa and Mohammed Hassar and Abdellah Akil and Pascal Pineau and Soumaya Benjelloun",
year = "2009",
month = "9",
doi = "10.1016/j.meegid.2009.05.012",
language = "English (US)",
volume = "9",
pages = "877--881",
journal = "Infection, Genetics and Evolution",
issn = "1567-1348",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population

AU - Ezzikouri, Sayeh

AU - El feydi, Abdellah Essaid

AU - Benazzouz, Mustapha

AU - Afifi, Rajae

AU - El kihal, Latifa

AU - Hassar, Mohammed

AU - Akil, Abdellah

AU - Pineau, Pascal

AU - Benjelloun, Soumaya

PY - 2009/9

Y1 - 2009/9

N2 - Hepatocellular carcinoma is a major malignant tumor characterized in all areas by the disparity of risk between genders. The molecular bases of such disparity are still poorly understood. DNA-methyltransferase-3B (DNMT3B) may play an oncogenic role during tumorigenesis, and its genetic variants have been consistently associated with risk of several cancers, but a single study has investigated their roles in hepatocellular carcinoma (HCC). Polymorphisms of the DNMT3B gene may influence its activity on DNA methylation in several cancers, thereby modulating susceptibility to tumorigenesis. To test this hypothesis, we investigated the association between single nucleotide polymorphism -149C > T (rs2424913) in the promoter region DNMT3B and risk of HCC in a Moroccan population. In this case-control study, the DNMT3B SNP was genotyped by polymerase chain reaction-restriction fragment length polymorphism in 96 HCCs patients and 222 healthy controls that matched for age, sex and ethnicity. Overall, we found that, the DNMT3B 149 TT genotype was not significantly associated with increased risk of HCC (adjusted odds ratio (OR), 0.86, 95% CI, 0.41-1.80, P = 0.697). Stratification analysis detected, however, a trend towards a profound risk in the female subset of patients (OR = 2.04, 95% CI, 0.77-5.42) and a lesser risk for HCV-infected patients (OR = 1.33, 95% CI, 0.43-4.17). Our findings contrast with those of previous studies performed in various cancers, which showed that individuals carrying at least one T allele have a significantly increased risk of developing cancer. In addition, we provide genetic evidence for the major difference of HCC risk between men and women. Further mechanistic studies are needed to unravel the underlying molecular mechanisms.

AB - Hepatocellular carcinoma is a major malignant tumor characterized in all areas by the disparity of risk between genders. The molecular bases of such disparity are still poorly understood. DNA-methyltransferase-3B (DNMT3B) may play an oncogenic role during tumorigenesis, and its genetic variants have been consistently associated with risk of several cancers, but a single study has investigated their roles in hepatocellular carcinoma (HCC). Polymorphisms of the DNMT3B gene may influence its activity on DNA methylation in several cancers, thereby modulating susceptibility to tumorigenesis. To test this hypothesis, we investigated the association between single nucleotide polymorphism -149C > T (rs2424913) in the promoter region DNMT3B and risk of HCC in a Moroccan population. In this case-control study, the DNMT3B SNP was genotyped by polymerase chain reaction-restriction fragment length polymorphism in 96 HCCs patients and 222 healthy controls that matched for age, sex and ethnicity. Overall, we found that, the DNMT3B 149 TT genotype was not significantly associated with increased risk of HCC (adjusted odds ratio (OR), 0.86, 95% CI, 0.41-1.80, P = 0.697). Stratification analysis detected, however, a trend towards a profound risk in the female subset of patients (OR = 2.04, 95% CI, 0.77-5.42) and a lesser risk for HCV-infected patients (OR = 1.33, 95% CI, 0.43-4.17). Our findings contrast with those of previous studies performed in various cancers, which showed that individuals carrying at least one T allele have a significantly increased risk of developing cancer. In addition, we provide genetic evidence for the major difference of HCC risk between men and women. Further mechanistic studies are needed to unravel the underlying molecular mechanisms.

KW - DNA-methyltransferase-3B

KW - Hepatocellular carcinoma

KW - Polymorphism

UR - http://www.scopus.com/inward/record.url?scp=67651119885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651119885&partnerID=8YFLogxK

U2 - 10.1016/j.meegid.2009.05.012

DO - 10.1016/j.meegid.2009.05.012

M3 - Article

VL - 9

SP - 877

EP - 881

JO - Infection, Genetics and Evolution

JF - Infection, Genetics and Evolution

SN - 1567-1348

IS - 5

ER -